RxDoctor Payments Data

Amanda Biery, PA

Medical · Spring, TXNPI 1124537477

Payments from drug & device makers

What this record shows

This record is dominated by food and beverage: $8,132 of the $9,300 with a category attached, or 87.4%. It is spread thinly across 25 manufacturers, the largest accounting for just 11.2% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2021 at $3,217 and has fallen 92.9% since, to $228 in 2025. Among medical clinicians in TX with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$9,300in general payments, 2019–2025

Across 496 payments — averaging $18.75 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Novartis$1K
  • Lilly USA, LLC$873
  • Journey Medical Corporation$857
  • Sanofi$841
  • AbbVie$805
  • Regeneron Healthcare Solutions, Inc.$620
  • plus $4K from 19 others

What the payments were for

  • Consulting fees$5005%
  • Speaking & faculty fees$841%
  • Food & beverage$8,13287%
  • Education$5846%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$9,300 in reported general payments places this provider in the 90th percentile of 1,490 medical providers in Texas.

See all medical providers in Texas →

Medicare billing

Part B allowed, 2024
$20,925
Medicare patients
96
Services billed
397

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Ketoconazole41$914
Clobetasol Propionate24$829
Dapsone12$808
Triamcinolone Acetonide33$532
Fluorouracil11$523
Ciclopirox16$444
Doxycycline Hyclate12$417
Mupirocin17$197
Hydrocortisone16$128
Cephalexin13$113

Paid to pharmacies, not to this prescriber.

Other medical in Spring

See the full list for Texas →

Where these figures come from

Is this you, or does something look wrong? →